To this end, we used ELISPOT to assess IFN-γ production in response to the MUC1 vaccine in tumor-draining lymph nodes (TDLNs) of tumor-bearing mice from the untreated, vaccine alone, indomethacin alone, and indomethacin + vaccine mice. This evidence concerns the gene MUC1 and neoplasm.